FDA Brief

Warning letters Drugs

FDA warning letter to

GuangZhou YouXing Cosmetic Co., Ltd

High riskIssued Sep 30, 2021Posted Oct 12, 2021Center for Drug Evaluation and Research | CDER

FDA found Guangzhou YouXing's V&W hand sanitizer labeled 75% ethanol contained only 35%, and refused its import as adulterated and unapproved.

What happened

FDA laboratory-tested a batch of V&W Advance Hand Sanitizer Refreshing Gel (240ml/8oz) that was labeled as made at the firm's Guangzhou facility after it was offered for import into the United States. The shipment was detained and refused admission at the border, and testing found the product contained an average of only 35% v/v ethanol against the 75% stated on the label. FDA had already publicly warned consumers about the subpotency on October 1, 2020, and placed all of the firm's drugs on Import Alert 66-78 on October 8, 2020.

What FDA found

  1. The hand sanitizer was labeled as 75% ethanol but tested at only 35%, so its strength fell below what the label claimed.

    Section 501(c) of the FD&C Act, 21 U.S.C. 351(c)
  2. The weak product shows the firm's quality assurance is not working as required by current good manufacturing practice (CGMP), the set of rules for how drugs must be made and tested.

    Section 501(a)(2)(B) of the FD&C Act, 21 U.S.C. 351(a)(2)(B)
  3. The product is a new drug sold without FDA approval and does not meet the conditions for nonprescription drugs marketed without an application.

    Sections 505(a) and 301(d) of the FD&C Act, 21 U.S.C. 355(a) and 331(d)
  4. The label's 75% ethanol claim is false and misleading, which makes the product misbranded.

    Section 502(a) of the FD&C Act, 21 U.S.C. 352(a)
  5. The product is misbranded because it is a nonprescription drug that does not comply with the requirements for marketing under section 505G.

    Section 502(ee) of the FD&C Act, 21 U.S.C. 352(ee)

What FDA wants

FDA asks the firm to investigate why the product labeled 75% ethanol tested at 35%, list all raw materials and suppliers, list and reconcile all batches shipped to the United States, and provide complete batch records. The firm must reply in writing within 15 working days, and FDA recommends hiring a qualified CGMP consultant before making drugs for the U.S. market again.

Who should pay attention

  • brands and distributors that buy hand sanitizer from this contract manufacturer
  • U.S. importers and brokers of over-the-counter antiseptic drugs
  • retailers and repackagers selling imported hand sanitizer

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. Macau-Union Pharmaceutical Limited

    Macau-Union Pharmaceutical failed CGMP and sold unapproved, misbranded Bamboo Pharmacy OTC pain rubs in the U.S.

    High risk
  2. ImprimisRx NJ

    FDA found insanitary sterile compounding and subpotent timolol-latanoprost eye drops at ImprimisRx NJ.

    High risk
  3. Shuzy Rock Inc.

    FDA warns Shuzy Rock Inc. of adulterated hand sanitizers made under insanitary conditions and found below labeled alcohol strength.

    High risk
  4. Guangzhou Zhongkebaishi Health Industry Co., Ltd.

    Guangzhou Zhongkebaishi's Hand Sanitizer Gel, labeled 75% ethanol, tested at 51% and was refused US import.

    High risk